-
Most Recent
Search Results
240 results for NOVL
Will ‘Casual Vacany’ Bump ‘Fifty Shades of Grey’?
The ‘Harry Potter’ author is moving into adult themes in her new book. With 1 million pre-orders already, she already has another hit.
Sorrento Therapeutics Remains a Buy Between $6 and $6.50
Sorrento Therapeutics has seen SRNE stock close between $5.76 and $8.20 in the past month. Here’s why it’s time for investors to be careful.
As the Purchase Orders Build, Workhorse Group Will Ultimately Succeed
Workhorse Group got another purchase order for its C-1000. Eventually, this will translate into real growth for WKHS stock.
Is It Time to Buy Sorrento Stock After Its Month-Long Swoon?
Sorrento stock has lost 50% over the past month. Investors have grown impatient with the company’s Covid-19 efforts. Time to buy or sell?
Barnes & Noble Inc.: Dangerously Close to a Cash Crunch (BKS)
As a retailer, Barnes and Noble is still well-loved. As a company, however, Barnes & Noble is increasingly less viable.
10 Worst “Strong Sell” Stocks This Week — EXK MCP WLT and more
This week, these ten stocks have the worst year-to-date performance. Each of these also rates an “F” (“strong sell”) on Portfolio Grader. Since the beginning…
Is Barnes & Noble Still Undervalued?
Barnes & Noble has shed a good chunk of its value in the last five-years, but went on a nice run this week. Does the…
BKS Stock Still Doomed After College Spinoff Plans
Barnes & Noble (BKS) stock is up today after announcing a spinoff of its college bookstore business. I’m afraid it’s too little, too late for…
Ayro Was a Good Speculative Buy When It Cost Less
Speculation pushed Ayro stock to $10.60 before direct offering took steam out of it. Trading in $6s, it’s tough to know where it’s headed.
Barnes & Noble, Inc. (BKS) Stock Drops on Disappointing Sales
Barnes & Noble, Inc. (BKS) shares were sinking during regular trading hours Thursday as the company’s sales underwhelm once again Thursday.
The Vaccine Race Is Far From Over, And That’s Good News for Novavax
Bill Gates expects Novavax’s vaccine to be effective against Covid-19. Despite Pfizer being first, NVAX stock is still bound to benefit.
Hold Novo Nordisk Shares for Consistent International Growth
The company’s value chain may have been shaken by Covid-19 but it wasn’t broken, so Novo Nordisk stock holders should stay invested.
Ditch Barnes & Noble (BKS) Stock NOW Before Things Get Worse!
Shares of Barnes & Noble (BKS) stock are plunging on Wednesday after whiffing on first-quarter earnings. It’s time to get out!
10 Worst “Strong Sell” Stocks This Week — RBY EGO MCP and more
This week, these ten stocks have the worst year-to-date performance. Each of these also rates an “F” (“strong sell”) on Portfolio Grader. Since the beginning…
Novavax Steals Some of Pfizer’s Thunder With Fast Track Designation
Novavax delivered good news Nov. 9. It announced its Covid-19 vaccine’s been fast-tracked by the FDA. That’s very good news for NVAX stock.
9 Biotechnology Stocks to Sell Now
This week, the overall grades of nine Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
Barnes & Noble: Make a Profitable Divorce
If done quickly, a formal split of Barnes & Noble’s two businesses could unlock tremendous shareholder value. However, time is of the essence.
Barnes & Noble Plays Into Amazon’s Hands
Barnes & Noble’s Nook price cut has only led to heightened consumer interest in a soon-to-be updated Kindle from Amazon.
Wednesday Apple Rumors: Apple Lands Another Blow Against Samsung Galaxy Tab
Germany court prevents Samsung from releasing Galaxy Tab in all European Union countries except the Netherlands.
13 Biotechnology Stocks to Buy Now
The grades of 13 Biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong…
2 – 10 of 240 results
